Dawnrays Pharma was founded in December 1995, it is principally engaged in the development, manufacture and sales of cephalosporin antibiotics and system specific medicines. Dawnrays Pharmaceutical (Holdings) Limited listed on the main board of The Hong Kong Stock Exchange on July 11, 2003 with stock code 02348.HK.